Erythropoiesis-stimulating Agents Associated with Higher Risk of Venous Thromboembolism

EurekAlert! -- Use of erythropoiesis-stimulating agents is associated with an increased risk of venous thromboembolism, according to study published online November 10 in the Journal of the National Cancer Institute.